Investing.com - Portage Biotech Inc reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Portage Biotech Inc announced earnings per share of $-0.06 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.29 on revenue of $0.00.
Portage Biotech Inc shares are down 44% from the beginning of the year , still down 61.32% from its 52 week high of $15.41 set on Tuesday, November 30, 2021.
Portage Biotech Inc follows other major Healthcare sector earnings this month
Portage Biotech Inc's report follows an earnings beat by Eli Lilly on Tuesday, November 1, 2022, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
Pfizer had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.78 on revenue of $22.6B, compared to forecast for EPS of $1.44 on revenue of $21.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar